Literature DB >> 3139220

A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy.

M E Price1, S P Fisher-Hoch, R B Craven, J B McCormick.   

Abstract

Several viral infections have been reported to result in more severe disease in pregnant than non-pregnant women, but the relative risks have not been well characterised. This has now been done for Lassa fever in a prospective study of 68 pregnant and 79 non-pregnant women who were admitted to hospital in Sierra Leone with confirmed Lassa fever. Lassa fever was the main cause of maternal mortality in the hospital, accounting for 25% of maternal deaths. Twelve of 40 patients in the third trimester died, compared with two of 28 in the first two trimesters and 10 of 79 non-pregnant women. The odds ratio for death in the third trimester compared with the first two trimesters was 5.57 (95% confidence intervals 1.02 to 30.26). The condition of the mother improved rapidly after evacuation of the uterus, whether by spontaneous abortion, evacuation of retained products of conception, or normal delivery; 10 of 26 women without uterine evacuation died, but only four of 39 women with evacuation died (p = 0.0016). The odds ratio for death with pregnancy intact was 5.47 (95% confidence interval 1.35 to 22.16). Fetal and neonatal loss was 87%. The risk of death from Lassa fever in the third trimester is significantly higher than that in the first two trimesters and higher than that for non-pregnant women, but evacuation of the uterus can significantly improve the mother's chance of survival.

Entities:  

Mesh:

Year:  1988        PMID: 3139220      PMCID: PMC1834487          DOI: 10.1136/bmj.297.6648.584

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  13 in total

1.  Lassa fever in Panguma Hospital, Sierra Leone, 1973-6.

Authors:  E Keane; H M Gilles
Journal:  Br Med J       Date:  1977-05-28

2.  Differential effect of cigarette smoking on recirculating T lymphocyte subsets in pregnant women.

Authors:  Y C Smart; J Cox; T K Roberts; M W Brinsmead; R C Burton
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

3.  Lassa fever in the Eastern Province of Sierra Leone, 1970-1972. I. Epidemiologic studies.

Authors:  D W Fraser; C C Campbell; T P Monath; P A Goff; M B Gregg
Journal:  Am J Trop Med Hyg       Date:  1974-11       Impact factor: 2.345

4.  A hospital epidemic of Lassa fever in Zorzor, Liberia, March-April 1972.

Authors:  T P Monath; P E Mertens; R Patton; C R Moser; J J Baum; L Pinneo; G W Gary; R E Kissling
Journal:  Am J Trop Med Hyg       Date:  1973-11       Impact factor: 2.345

Review 5.  Epidemiology of infection in pregnancy.

Authors:  B J Brabin
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

Review 6.  Cell-mediated immunity and pregnancy.

Authors:  M M Lederman
Journal:  Chest       Date:  1984-09       Impact factor: 9.410

7.  Pathologic and virologic study of fatal Lassa fever in man.

Authors:  D H Walker; J B McCormick; K M Johnson; P A Webb; G Komba-Kono; L H Elliott; J J Gardner
Journal:  Am J Pathol       Date:  1982-06       Impact factor: 4.307

Review 8.  Pregnancy-associated depression of cell-mediated immunity.

Authors:  E D Weinberg
Journal:  Rev Infect Dis       Date:  1984 Nov-Dec

9.  Lassa fever. Effective therapy with ribavirin.

Authors:  J B McCormick; I J King; P A Webb; C L Scribner; R B Craven; K M Johnson; L H Elliott; R Belmont-Williams
Journal:  N Engl J Med       Date:  1986-01-02       Impact factor: 91.245

10.  No evidence for increased risk of Lassa fever infection in hospital staff.

Authors:  C G Helmick; P A Webb; C L Scribner; J W Krebs; J B McCormick
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

View more
  63 in total

Review 1.  Lassa fever: epidemiology, clinical features, and social consequences.

Authors:  J Kay Richmond; Deborah J Baglole
Journal:  BMJ       Date:  2003-11-29

Review 2.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

3.  Genomic profiling of host responses to Lassa virus: therapeutic potential from primate to man.

Authors:  Juan C Zapata; Maria S Salvato
Journal:  Future Virol       Date:  2015-03-13       Impact factor: 1.831

4.  Adjuvant formulated virus-like particles expressing native-like forms of the Lassa virus envelope surface glycoprotein are immunogenic and induce antibodies with broadly neutralizing activity.

Authors:  Helena Müller; Sarah Katharina Fehling; Jens Dorna; Richard A Urbanowicz; Lisa Oestereich; Yvonne Krebs; Larissa Kolesnikova; Martin Schauflinger; Verena Krähling; N'Faly Magassouba; Elisabeth Fichet-Calvet; Jonathan K Ball; Andreas Kaufmann; Stefan Bauer; Stephan Becker; Veronika von Messling; Thomas Strecker
Journal:  NPJ Vaccines       Date:  2020-08-04       Impact factor: 7.344

Review 5.  Risks associated with viral infections during pregnancy.

Authors:  Karen Racicot; Gil Mor
Journal:  J Clin Invest       Date:  2017-05-01       Impact factor: 14.808

6.  The unique immunological and microbial aspects of pregnancy.

Authors:  Gil Mor; Paulomi Aldo; Ayesha B Alvero
Journal:  Nat Rev Immunol       Date:  2017-06-19       Impact factor: 53.106

7.  Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene.

Authors:  S P Fisher-Hoch; J B McCormick; D Auperin; B G Brown; M Castor; G Perez; S Ruo; A Conaty; L Brammer; S Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

8.  Identification of protective Lassa virus epitopes that are restricted by HLA-A2.

Authors:  Jason Botten; Jeff Alexander; Valerie Pasquetto; John Sidney; Polly Barrowman; Joey Ting; Bjoern Peters; Scott Southwood; Barbara Stewart; Maria P Rodriguez-Carreno; Bianca Mothe; J Lindsay Whitton; Alessandro Sette; Michael J Buchmeier
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 9.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

Review 10.  Emerging and zoonotic infections in women.

Authors:  Regan N Theiler; Sonja A Rasmussen; Tracee A Treadwell; Denise J Jamieson
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.